Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/17331
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Monitoring enzyme replacement therapy in Fabry disease - Role of urine globotriaosylceramide |
Author: | Whitfield, Phillip D. Calvin, J. Hogg, S. O'Driscoll, E. Halsall, D. Burling, K. Macguire, G. Wright, N. Cox, T. M. Meikle, Peter John Deegan, P. B. |
Citation: | Journal of Inherited Metabolic Disease, 2005; 28:21-33 |
Publisher: | Kluwer Academic Publ |
Issue Date: | 2005 |
ISSN: | 0141-8955 |
School/Discipline: | School of Paediatrics and Reproductive Health : Paediatrics |
DOI: | 10.1007/s10545-005-4415-x |
Appears in Collections: | Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.